abiraterone,olaparib
astrazeneca,merck
['propel', 'gu ', 'merck', 'astrazeneca', '$azn']
$azn astrazeneca and merck present final results of key secondary overall survival endpoint from phase iii propel trial at asco gu cancers symposium 1/3
¬ Retweeting Bloomberg's Feed all in one place.

¬ Market & Stock Updates

¬ I'm Barry Bloomberg putting out the fastest updates!

¬ Making your life easier.